期刊文献+

Ready for ctDNA-guided treatment decisions in colorectal cancer?

下载PDF
导出
摘要 With the improved detection sensitivity and diagnostic accuracy,circulating tumor DNA(ctDNA)has emerged as a highly valuable biomarker in precision oncology for colorectal cancer(CRC).ctDNA has been well established as a strong prognostic indicator in predicting re-currence after radical surgery of CRC.
出处 《Journal of the National Cancer Center》 2023年第1期1-3,共3页 癌症科学进展(英文)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部